DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; HP; HPR; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; ASGR1; CD14; IGLC6; IGLC2; IGLC3; FOLR2; IGHV1-2; FCGR2B; MASP1; PPT1; HBA1; IGLV3-21; LRP2; CLEC9A; FCGR1B; CXCL16; STAB1; DAB2;	GO:0006898~receptor-mediated endocytosis	75	160	46.875	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; C1R; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; C1QA; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD55; C1S; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV1-45; IGHV3-21; IGHV5-51; IGHV3-20; IGHV3-35; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHE; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	96	161	59.6273291925466	0	0	0	0	0	0	0
up	TNFRSF10B; TNFRSF13B; LILRA1; LILRB5; ADAP1; TRPA1; PRL; IFNB1; IFNG; IL2RA; CD3D; GP1BA; INHBA; CD14; MET; CD3G; SAG; CXCR1; LAMA1; KLRC1; NUP62; IFNGR2; GLP1R; IFNAR2; CXCR3; TNFSF10; CCR5; IRF9; FADD; ADGRE1; LILRB2; CLEC1A; TNFRSF14; CD101; IL17RA; DOK1; MYD88; BAG1; ADGRE3; CLEC1B; CLEC4A; SIGLEC9; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV5-3; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; PDCD1LG2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	92	268	34.3283582089552	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHE; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; LYN; IGLC6; IGLC2; IGLC3; FCER1A; IGHV1-2; PSMB8; PSMB9; FCER1G; PSMB10; PSMB3; MAPK10; LILRA4; IGLV3-21; MS4A2; PSME1; PSMA8; PSMF1; LAT2;	GO:0038095~Fc-epsilon receptor signaling pathway	73	171	42.6900584795322	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; ARPC1B; ARPC3; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; LYN; CD3G; IGLC6; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; ARPC4; ACTB; IGLV3-21; PRKCD;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	70	135	51.8518518518518	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; TNFRSF10B; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; GYPA; IGLV7-43; CD74; IGKV1-16; IGKV1D-39; IGKV3-11; GYPB; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; LYN; DBH; CD48; IGLC6; IGLC2; IGLC3; ATP1B2; SELP; IGHV1-2; ITGA3; PTPN6; FCER1G; CEACAM8; L1CAM; CEACAM3; IGLV3-21; SELPLG; ANGPT1; CD177; SIRPG; CD84;	GO:0050900~leukocyte migration	80	193	41.4507772020725	0	0	0	0	0	0	0
down	EVPLL; FOXN1; TGM5; KRT34; SCEL; GJB5; KRT14; KRT5; DSP; SPRR1B; SPRR2E; SPRR2D; CRABP2; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT2; KLK7; EMP1; ELF3; FABP5; BNC1; KRT32; KRT31; CST6; ZNF750; CERS3; ACER1; GRHL3; EVPL; SPRR2F; SPRR2G; GRHL1; CALML5; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	42	82	51.219512195122	0	0	0	0	0	0	0
down	FOXN1; SCEL; CSTA; ANXA1; IVL; KRT16; KRT10; DSP; FLG; SPRR1B; TGM1; EPHA2; S100A7; SPRR1A; SPRR2B; SPRR2A; AKR1C3; POU3F1; TGM3; CERS3; ACER1; EVPL; SPRR2F; SPRR2G; SPRR3; INTU;	GO:0030216~keratinocyte differentiation	26	53	49.0566037735849	0	0	0	0	0	0	0
down	KRT33A; KRT34; KRT37; KRT75; KRT14; KRT6A; KRT6B; KRT16; KRT3; KRT10; KRT13; KRT5; JUP; DSP; KRT4; CASP14; SFN; DSG3; KRT9; KRT20; KRT2; KRT6C; KRT76; DSG1; KRT17; TGM3; PKP1; KRT33B; KRT32; DSC3; KRT31; KRT24; LCE3E; LCE1C; LCE3A; LCE5A; KRT40; KRT80; KRT27; ABCA12; HRNR; KRT78; SPRR4; CNFN; KRTAP3-2; PKP3;	GO:0031424~keratinization	46	181	25.414364640884	0	0	0	0	0	0	0
down	DSP; KRT9; KRT20; KRT2; KRT17; TCHH;	GO:0045109~intermediate filament organization	6	18	33.3333333333333	0.00010298212604609	0.00527658566013053	0.340870837212564	0.347461693279513	0.314198466566626	0.340870837212564	0.0459127227193732
down	GFRA3; NFASC; ERBB3; EDNRB; UGT8; NTF3; NTF4;	GO:0007422~peripheral nervous system development	7	27	25.9259259259259	0.00010321714687866	0.00527658566013053	0.341545539021501	0.348254653568615	0.314709080833049	0.341545539021501	0.0459127227193732
down	CXCL11; MCF2L; DEFB4A; GPR37; RGS5; RGS11; ADGRL2; GNA14; GAST; CXCL10; ANXA1; EDN1; CCK; NMB; SAA1; EDN3; PDE6A; ADCYAP1; ADRA2C; EDN2; EDNRB; BDKRB2; PTGER1; APLNR; ADCYAP1R1; AKR1C3; GPR1; BDKRB1; SCTR; NMU; AKR1C2; PDE1A; DEFB1; GNAI1; CX3CL1; CXCL9; ADGRF1; ARHGEF16; PREX2; TAS1R3; ADGRG6; ADGRF5; ADGRF4; ADGRF2; NGEF; OR2I1P; ADGRV1; QRFPR; OXGR1; CCL19; GPR62; ADGRL4; ARHGEF4; LPAR3; RAPGEFL1; FZD10; GNG4; CCL11; CGB7; GPR87; MRGPRX3; CCL22; GPR78; GNG12; CCL17;	GO:0007186~G protein-coupled receptor signaling pathway	65	1152	5.64236111111111	0.00012255909757419	0.00614801259139925	0.405425494775431	0.413514395215327	0.353789704580379	0.405425494775431	0.0534951985176615
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.00013003943544975	0.00634920348869299	0.4299103735969	0.438753055207484	0.366061010791069	0.4299103735969	0.055245804397313
down	PLA2G10; PLA2G2A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	6	19	31.5789473684211	0.00013172621345836	0.00634920348869299	0.435355135479882	0.444444244208509	0.36877441470486	0.435355135479882	0.055245804397313
down	CYP1A1; MT1G; AQP1; MT1X; MT1A; MT1M; MT1H;	GO:0071280~cellular response to copper ion	7	29	24.1379310344828	0.00015120521691658	0.00708564447050767	0.499430831475475	0.510166401876552	0.40048529927813	0.499430831475475	0.061653738007246
down	CLDN7; TF; EPCAM; DUOXA2; CCL19; DUOX2;	GO:2000147~positive regulation of cell motility	6	20	30	0.00016647449797502	0.00746189933923948	0.549532317815548	0.561684956167725	0.425342342326182	0.549532317815548	0.0649276136860633
down	ADGRV1; GABRQ; GABRB2; HTR3B; CHRNB4; GABRA3; GABRR1; GABRE; GABRA4;	GO:0050877~nervous system process	9	52	17.3076923076923	0.00016732026207	0.00746189933923948	0.55215686483101	0.564538564224191	0.426666668278508	0.55215686483101	0.0649276136860633
down	DSG1; TJP1; CDH19; CDH8; PKP3; PKP1; CDH17; CTNND1;	GO:0007043~cell-cell junction assembly	8	43	18.6046511627907	0.00024824584297167	0.0100599339492773	0.817225315062747	0.837581474186424	0.520414148201289	0.817225315062747	0.0875336794924602
down	ADGRL2; CXCL10; INHA; EDN1; EDN3; MIF; EDN2; EPHA1; EDNRB; BDKRB2; ADCYAP1R1; SCTR; ADGRF1; ADGRG6; ADGRF5; ADGRF4; ADGRF2; ADGRV1; MAGI1; ADGRL4; CBLC; ANXA1;	GO:0007166~cell surface receptor signaling pathway	22	268	8.2089552238806	0.00028881906678246	0.0114644180155769	0.950214729714307	0.974475531324034	0.555976703556244	0.950214729714307	0.0997544016892065
down	SAA1; EDN2; EDNRB; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	5	14	35.7142857142857	0.00030639393747811	0.0118824499431166	1	1	0.571071627109349	0.999999575044437	0.103391788668821
down	UGT1A9; UGT1A6; UGT1A1; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	5	14	35.7142857142857	0.00030639393747811	0.0118824499431166	1	1	0.571071627109349	0.999999575044437	0.103391788668821
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.00032298869225511	0.0123585565197047	1	1	0.58396355559724	0.999999575044437	0.107534495836625
down	CYP1A1; GLI2; BMP2; CCNB1; FOXF1; KLF5; IL18; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	8	45	17.7777777777778	0.00032599630416529	0.0123585565197047	1	1	0.585815358585043	0.999999575044437	0.107534495836625
down	OVOL1; GJB3; KRT9; DHCR24; TFAP2B; ABCB6; DSP;	GO:0043588~skin development	7	34	20.5882352941176	0.00035274045503985	0.0132238477256053	1	1	0.603186178118156	0.999999575044437	0.115063583350206
down	DEFB4A; CXCL10; SAA1; SAA2; MIF; NTF3; CX3CL1; GPNMB;	GO:0050918~positive chemotaxis	8	46	17.3913043478261	0.0003717198621409	0.0136324219006893	1	1	0.615238590260441	0.999999575044437	0.118618676362847
down	UPK2; SPDEF; FGF1; HOXD4; EDN3; HOXB1; FLG; MEOX2; ELF3; ODF4; SPATA19; CCL17; AMN; EBF3; PAQR5; EHF; NPAP1; THEG; DKK4; NKX1-2; HOOK1; EPHA2; TYRO3; ROR1; EPHA1; FGFR3; CDH19; CDH8; ERBB3; MST1R; SPINK6; CDH17; KDR; SPINK5;	GO:0007275~multicellular organism development	34	513	6.62768031189084	0.00037709794532692	0.013680951263796	1	1	0.61844063033615	0.999999575044437	0.11904094093611
down	PLA2G4B; PLA2G4D; GDPD3; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	5	15	33.3333333333333	0.00039745448559536	0.0141159098357763	1	1	0.630490736216647	0.999999575044437	0.122825610340918
down	ADCYAP1; GABRR1; GABRB2; FGF14; GABRA3; GABRE; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	7	35	20	0.0004113214782403	0.0144562361206539	1	1	0.63782638652563	0.999999575044437	0.125786863575138
down	ALOX12B; DKK1; AGR2; AR; BMP2; BMP7; ERBB3; HOXD3; ID1; WNT3; LCN2; POU3F1; PKP1; NR0B2; OCLN; IL34; SLC26A9; CAMK2N1; SEC16B; OVOL2; TRIM6; EPB41L4B; PKP3; IL1F10; IL36A; IL36G; IL36B;	GO:0010628~positive regulation of gene expression	27	374	7.2192513368984	0.00043417665073197	0.0149480818323438	1	1	0.64808442963581	0.999999575044437	0.13006652039037
down	IL20RB; IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00046239682744686	0.0156012689580572	1	1	0.66076506642157	0.999999575044437	0.135750044039639
down	CYP2C9; CYP2C19; CYP2F1; CYP2J2; CYP2C18; CYP2E1;	GO:0042738~exogenous drug catabolic process	6	25	24	0.00046239682744686	0.0156012689580572	1	1	0.66076506642157	0.999999575044437	0.135750044039639
down	GJB6; GJB1; GJA1; GJB2;	GO:0016264~gap junction assembly	4	8	50	0.00047182752493457	0.015607314403228	1	1	0.664596348262249	0.999999575044437	0.135802646776659
down	AQP1; SCNN1A; SCNN1B; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.00047182752493457	0.015607314403228	1	1	0.664596348262249	0.999999575044437	0.135802646776659
down	MT1X; MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	5	16	31.25	0.0005075346619876	0.0160039434537027	1	1	0.677933170490834	0.999999575044437	0.139253802654689
down	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.0005075346619876	0.0160039434537027	1	1	0.677933170490834	0.999999575044437	0.139253802654689
down	EDN1; EDN3; EDN2; BDKRB2; ACE2;	GO:0019229~regulation of vasoconstriction	5	16	31.25	0.0005075346619876	0.0160039434537027	1	1	0.677933170490834	0.999999575044437	0.139253802654689
down	ALOX15B; ALOX12B; PON3; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	5	16	31.25	0.0005075346619876	0.0160039434537027	1	1	0.677933170490834	0.999999575044437	0.139253802654689
down	EDN1; EDN3; EDN2; EDNRB; BDKRB2;	GO:0042310~vasoconstriction	5	16	31.25	0.0005075346619876	0.0160039434537027	1	1	0.677933170490834	0.999999575044437	0.139253802654689
down	FOXN1; DKK1; HOXC13; SOX18; NSDHL; ZDHHC21; LGR4;	GO:0001942~hair follicle development	7	37	18.9189189189189	0.00055170776824198	0.016921938782323	1	1	0.694382426541093	0.999999575044437	0.147241480235494
down	CLDN1; OCLN; MARVELD2; PARD3; POF1B; CRB3; PARD6G;	GO:0070830~bicellular tight junction assembly	7	38	18.4210526315789	0.00063489809325711	0.0189570457225621	1	1	0.724418724406373	0.999999575044437	0.164949389605274
down	ALOX15B; PLA2G10; ALOX12B; PLA2G4B; MGLL; ALOXE3;	GO:0019369~arachidonic acid metabolic process	6	27	22.2222222222222	0.00065752893591941	0.018998064167709	1	1	0.732323454563726	0.999999575044437	0.165306300043143
down	AKR1B10; AKR1C3; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	4	9	44.4444444444444	0.00066374678309444	0.018998064167709	1	1	0.734406889376643	0.999999575044437	0.165306300043143
down	AKR1B10; AKR1C3; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	4	9	44.4444444444444	0.00066374678309444	0.018998064167709	1	1	0.734406889376643	0.999999575044437	0.165306300043143
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.00066442548067269	0.018998064167709	1	1	0.734707651789095	0.999999575044437	0.165306300043143
up	IFNG; HLA-B; HLA-H; HLA-DRA; HLA-DQA2; HLA-A; HLA-DPB1; HLA-C; IRF1; IRF2; IFNGR1; VCAM1; PML; IFNGR2; B2M; IRF9; IRF8; PRKCD; NMI; IRF4; FCGR1B; TRIM34; TRIM8;	GO:0060333~interferon-gamma-mediated signaling pathway	23	72	31.9444444444444	0.00074510457991472	0.179605684929921	1	1	0.999999999921875	0.999999999921875	1
down	COBL; CYP1A1; CCNB1; CLDN18; FOXF1; LGR4;	GO:0048565~digestive tract development	6	28	21.4285714285714	0.00077631003356759	0.0218272504438089	1	1	0.773204793433325	0.999999575044437	0.18992366691307
down	ALOX12B; GSTA1; CYP2J2; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	5	18	27.7777777777778	0.00079448280881466	0.0221535950160387	1	1	0.779387635447188	0.999999575044437	0.192763262215952
down	OVOL1; FOXP2; SOX15; DKK1; SPDEF; KLF8; IL33; EDN1; GLI2; AR; SCGB1A1; BMP2; HOXD8; EFNA1; EDNRB; HOXD9; HOXA7; HOXC8; HNF1B; SOX18; MMP12; FOXA1; FOXF1; KLF5; TRIM29; SIM2; CRYM; HES5; MLIP; KCTD1; NRARP; WWC1; BCL6B; SDR16C5; TFAP2B; TFAP2C; OVOL2; IRX2; FOXQ1; PEG3; MYOZ1; TFCP2L1; NOTCH3; BARX2; ID1; HES2; NR0B2; ID4;	GO:0000122~negative regulation of transcription by RNA polymerase II	48	847	5.66706021251476	0.00080799525086994	0.0223457047248786	1	1	0.783755393343843	0.999999575044437	0.194434850694143
down	NFASC; MAL; ADGRG6; KLK6; FAM126A; MAL2; MALL; PLLP;	GO:0042552~myelination	8	53	15.0943396226415	0.00085858954398365	0.0233619445274263	1	1	0.798389329413847	0.999999575044437	0.203277374870963
down	CXCL11; CXCL10; APLNR; BDKRB1; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	6	29	20.6896551724138	0.00091098936836953	0.0242021899911716	1	1	0.813355505183731	0.999999575044437	0.210588533919255
down	EDN1; ADRA2C; EDNRB; FABP5; MGLL; TMEM100;	GO:0051930~regulation of sensory perception of pain	6	29	20.6896551724138	0.00091098936836953	0.0242021899911716	1	1	0.813355505183731	0.999999575044437	0.210588533919255
down	PLA2G10; PLA2G4B; PLA2G2A; PLD1; LIPI; PLA2G4D; PLA2G2F;	GO:0006654~phosphatidic acid biosynthetic process	7	41	17.0731707317073	0.00094543870730312	0.0249211734253183	1	1	0.823151798937841	0.999999575044437	0.216844565599215
down	ALOX15B; BRINP1; INHA; BMP2; BMP7; ADCYAP1; CAMK2N1;	GO:0045786~negative regulation of cell cycle	7	42	16.6666666666667	0.00107195085785783	0.0278212476493255	1	1	0.846841177707685	0.999999575044437	0.242078743965448
down	FOXN1; SOX15; HOXA6; HNF4A; ID4; IRX4; IRX3; HOXC5; MESP2; ECM1; DMRTA1; TFAP2C; DMRTA2; VGLL1; SOX7; DMRT3; STOX2; POU2F3; NHLH2; SP6; SPDEF; KLF8; HNF1B; HNF4G; FOXA1; GRHL3; TFCP2L1; FOXI2; KLF5; TFAP2B; GRHL1; HOPX; KLF15; TBL1Y; DLX3; FOXQ1; DLX5; EHF; ZNF878; ZNF57; ELF3; BARX2; SIM2;	GO:0006357~regulation of transcription by RNA polymerase II	43	747	5.75635876840696	0.00110334808934753	0.0281375237526701	1	1	0.852092790817572	0.999999575044437	0.244830731324498
down	CYP2E1; EDN1; SCGB1A1;	GO:0010193~response to ozone	3	4	75	0.00113417404575078	0.0281375237526701	1	1	0.856577965264181	0.999999575044437	0.244830731324498
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00113417404575078	0.0281375237526701	1	1	0.856577965264181	0.999999575044437	0.244830731324498
down	AKR1C3; AKR1C2; AKR1C1;	GO:0071395~cellular response to jasmonic acid stimulus	3	4	75	0.00113417404575078	0.0281375237526701	1	1	0.856577965264181	0.999999575044437	0.244830731324498
down	ANXA8; PLA2R1; ANXA1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00113417404575078	0.0281375237526701	1	1	0.856577965264181	0.999999575044437	0.244830731324498
down	TJP1; OCLN; TJP2;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.00113417404575078	0.0281375237526701	1	1	0.856577965264181	0.999999575044437	0.244830731324498
down	FUT1; FUT3; FUT2; FUT6;	GO:0036065~fucosylation	4	11	36.3636363636364	0.00120200654798053	0.0294041534144402	1	1	0.86664672109396	0.999999575044437	0.255851952279632
down	CTNND1; JUP; DSP; CDH8; CDH17; NECTIN4; CDH19;	GO:0034332~adherens junction organization	7	43	16.2790697674419	0.00121137442934416	0.0294041534144402	1	1	0.867876612708593	0.999999575044437	0.255851952279632
down	SCGB1A1; IDO1; GPNMB; IL20RB; VTCN1; PLA2G2F; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	7	43	16.2790697674419	0.00121137442934416	0.0294041534144402	1	1	0.867876612708593	0.999999575044437	0.255851952279632
down	NRG2; ERBB3; BTC; PTK6; GRB7; PTPRR;	GO:0038128~ERBB2 signaling pathway	6	31	19.3548387096774	0.00123360679952589	0.0295190733446833	1	1	0.87102674522886	0.999999575044437	0.256851895658178
down	ALOX12B; FA2H; CERS3; SPTSSB; ALOXE3; DEGS2;	GO:0046513~ceramide biosynthetic process	6	31	19.3548387096774	0.00123360679952589	0.0295190733446833	1	1	0.87102674522886	0.999999575044437	0.256851895658178
down	CLEC3B; BMP2; PTN; FGFR3; GPNMB; LGR4; TUFT1;	GO:0030282~bone mineralization	7	44	15.9090909090909	0.00136459943171674	0.0319733227959186	1	1	0.890184770106554	0.999999575044437	0.278206855436459
down	HOXB1; HOXD3; HOXA6; HOXA7; HOXD9; HOXD4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	7	44	15.9090909090909	0.00136459943171674	0.0319733227959186	1	1	0.890184770106554	0.999999575044437	0.278206855436459
down	SLC6A15; SLC6A17; SLC6A14; SLC6A1; SLC6A11; TMEM184A;	GO:0006810~transport	6	32	18.75	0.00142444135537101	0.0328396644255436	1	1	0.898822495239107	0.999999575044437	0.285745082915976
down	SRPX2; ANXA1; KDR; FGFBP1; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00143077376127887	0.0328396644255436	1	1	0.899956695844409	0.999999575044437	0.285745082915976
down	EDN1; EDNRB; ATP6V0A4; RHCG;	GO:0006885~regulation of pH	4	12	33.3333333333333	0.00156100828492511	0.0351122796889156	1	1	0.918938625353134	0.999999575044437	0.305519604008927
down	GPIHBP1; MFSD2A; MAL2; RAB17;	GO:0045056~transcytosis	4	12	33.3333333333333	0.00156100828492511	0.0351122796889156	1	1	0.918938625353134	0.999999575044437	0.305519604008927
down	EDN1; EDN3; EDN2; GPR62;	GO:0048016~inositol phosphate-mediated signaling	4	12	33.3333333333333	0.00156100828492511	0.0351122796889156	1	1	0.918938625353134	0.999999575044437	0.305519604008927
down	FABP5; SLC44A4; SLC44A3; MFSD2A; SLC44A5; LPIN3;	GO:0006656~phosphatidylcholine biosynthetic process	6	33	18.1818181818182	0.0016369606868436	0.0363362194566468	1	1	0.927437387831113	0.999999575044437	0.316169370884817
down	SAA1; CCL22; CX3CL1; CCL19; CCL17; CCL11;	GO:0048247~lymphocyte chemotaxis	6	33	18.1818181818182	0.0016369606868436	0.0363362194566468	1	1	0.927437387831113	0.999999575044437	0.316169370884817
down	NFASC; MAL; UGT8;	GO:0002175~protein localization to paranode region of axon	3	5	60	0.00177016520177253	0.0378008695619021	1	1	0.938191425488291	0.999999575044437	0.328913610909497
down	AQP1; RHBG; RHCG;	GO:0015696~ammonium transport	3	5	60	0.00177016520177253	0.0378008695619021	1	1	0.938191425488291	0.999999575044437	0.328913610909497
down	EDN1; EDN3; CPE;	GO:0030072~peptide hormone secretion	3	5	60	0.00177016520177253	0.0378008695619021	1	1	0.938191425488291	0.999999575044437	0.328913610909497
down	EDN1; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	3	5	60	0.00177016520177253	0.0378008695619021	1	1	0.938191425488291	0.999999575044437	0.328913610909497
down	KRT10; KRT2; TMEM79;	GO:0045684~positive regulation of epidermis development	3	5	60	0.00177016520177253	0.0378008695619021	1	1	0.938191425488291	0.999999575044437	0.328913610909497
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00177016520177253	0.0378008695619021	1	1	0.938191425488291	0.999999575044437	0.328913610909497
down	CIDEA; ID1; NOVA1; ACOT11; LGR4; HOXC10; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	7	47	14.8936170212766	0.00191638179349307	0.0406658627122366	1	1	0.950439801040532	0.999999575044437	0.353842541202076
down	GABRB2; GABRA4; GABRA3; GABRE;	GO:0051932~synaptic transmission, GABAergic	4	13	30.7692307692308	0.00198831114624587	0.0416680857604569	1	1	0.956346912343386	0.999999575044437	0.362563102542259
down	CYP1A1; HNF1B; HNF4A; ANXA1;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.00198831114624587	0.0416680857604569	1	1	0.956346912343386	0.999999575044437	0.362563102542259
down	ANXA1; EDN1; ADCYAP1; UGT1A1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	5	23	21.7391304347826	0.00202413550231673	0.0421569949680039	1	1	0.958731507873628	0.999999575044437	0.366817208194455
down	C1QC; SLPI; ANXA1; S100A8; KRT16; SAA1; MIF; C4BPB; S100A7; CRISP3; DEFB1; LCN2; MST1R; TRIM29; SUSD4; IL34; TRIL; NLRP10; PGLYRP4; PGLYRP3; RARRES2; LGR4; PLA2G2F; TRIM31; RNASE7; IL1RL2; POLR3B; IL36B; IL36G; IL36RN; IL36A;	GO:0045087~innate immune response	31	505	6.13861386138614	0.00206594266943538	0.042763745807822	1	1	0.961401393085428	0.999999575044437	0.372096679591802
down	BCHE; TH; PTN; SLC6A1; ARC; STRA6; PAK6; PAK5;	GO:0007612~learning	8	62	12.9032258064516	0.00212166707496553	0.0430598018431105	1	1	0.965251793095247	0.999999575044437	0.374672727728442
down	KLK8; GJA1; BMP7; UGT8; NYAP1; NTF3; NTF4; NCKAP1;	GO:0048812~neuron projection morphogenesis	8	62	12.9032258064516	0.00212166707496553	0.0430598018431105	1	1	0.965251793095247	0.999999575044437	0.374672727728442
down	SCNN1B; SCNN1G; FXYD3; SLC10A6; SLC5A8; SLC5A5; SLC38A3; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	9	77	11.6883116883117	0.00213129428209824	0.0430598018431105	1	1	0.96561265532672	0.999999575044437	0.374672727728442
down	CXCL14; CXCL10; IL18; SOSTDC1; CCL17;	GO:0045662~negative regulation of myoblast differentiation	5	24	20.8333333333333	0.00238007936095008	0.0469861804224357	1	1	0.9815580204134	0.999999575044437	0.408837004140357
down	CLDN4; CLDN1; ANXA1; OCLN; DUOX2;	GO:0090303~positive regulation of wound healing	5	24	20.8333333333333	0.00238007936095008	0.0469861804224357	1	1	0.9815580204134	0.999999575044437	0.408837004140357
down	EDN1; EDNRB; BTC; TFAP2B;	GO:0035810~positive regulation of urine volume	4	14	28.5714285714286	0.00249009776024867	0.0469861804224357	1	1	0.988461633839575	0.999999575044437	0.408837004140357
down	AKR1C3; AKR1C1; SDR16C5; BCO2;	GO:0042574~retinal metabolic process	4	14	28.5714285714286	0.00249009776024867	0.0469861804224357	1	1	0.988461633839575	0.999999575044437	0.408837004140357
down	SCNN1A; SCNN1B; SCNN1G; TFAP2B;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.00249009776024867	0.0469861804224357	1	1	0.988461633839575	0.999999575044437	0.408837004140357
down	COBL; BMP7; PTN; VLDLR;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.00249009776024867	0.0469861804224357	1	1	0.988461633839575	0.999999575044437	0.408837004140357
down	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	EDN1; EDN3; EDN2;	GO:0003100~regulation of systemic arterial blood pressure by endothelin	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	CYP2E1; UGT1A1; CYP2C19;	GO:0046483~heterocycle metabolic process	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	KRT76; ZDHHC21; ACER1;	GO:0048733~sebaceous gland development	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	ALOX15B; ALOX12B; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	ID1; FOXF1; STRA6;	GO:0060426~lung vasculature development	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.0025902280849357	0.0469861804224357	1	1	0.994574430867086	0.999999575044437	0.408837004140357
down	PIGR; BTC; GRB7; FAM83B; EPGN; FAM83A; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	7	50	14	0.00262687567303455	0.0471440346852051	1	1	0.996555525442677	0.999999575044437	0.410210528510739
down	FOXP2; ELN; HOXD9; MEOX2; MYH14; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	7	50	14	0.00262687567303455	0.0471440346852051	1	1	0.996555525442677	0.999999575044437	0.410210528510739
down	DEFB4A; S100A7; NOS2; DEFB1; LCE3A; NLRP10; IL22RA1; RARRES2; RNASE7;	GO:0050829~defense response to Gram-negative bacterium	9	80	11.25	0.00269922151954594	0.0479324916155157	1	1	0.999999575044437	0.999999575044437	0.417071064233877
down	GLI2; BMP2; FGFR3; GPLD1; HES5; WNT2B;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.00273532995449344	0.0480677253461503	1	1	0.999999575044437	0.999999575044437	0.418247762420328
down	AGR2; PTN; FOXF1; VWC2; EGFLAM; NPNT;	GO:0010811~positive regulation of cell-substrate adhesion	6	37	16.2162162162162	0.00273532995449344	0.0480677253461503	1	1	0.999999575044437	0.999999575044437	0.418247762420328
down	CTSV; GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	5	25	20	0.00277938570876002	0.0483383885636923	1	1	0.999999575044437	0.999999575044437	0.420602862111258
down	MT1A; MT1G; MT1H; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	5	25	20	0.00277938570876002	0.0483383885636923	1	1	0.999999575044437	0.999999575044437	0.420602862111258
up	HBZ; HBD; HBQ1; HBG1; HBG2; HBA1; HBM; CYGB;	GO:0015671~oxygen transport	8	14	57.1428571428571	0.00293667434536515	0.658420322255753	1	1	0.999999999921875	0.999999999921875	1
down	CTSV; NRTN; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.00307241877966591	0.0526210201146841	1	1	0.999999575044437	0.999999575044437	0.457866973332958
down	ADCYAP1; ADCYAP1R1; SCTR; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	4	15	26.6666666666667	0.00307241877966591	0.0526210201146841	1	1	0.999999575044437	0.999999575044437	0.457866973332958
down	MRLN; SCGB1A1; NQO1; UGT1A1; SERPINB3; UGT1A7; UGT1A8;	GO:0043086~negative regulation of catalytic activity	7	52	13.4615384615385	0.0032024079266858	0.0545703249729187	1	1	0.999999575044437	0.999999575044437	0.474828300072688
down	MT1A; MT1G; AKR1C3; MT1H; MT1X; MT1M;	GO:0071276~cellular response to cadmium ion	6	39	15.3846153846154	0.0034562992220627	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	EDN1; ADCYAP1; EDNRB; BDKRB1; NMU; DLG2; ALOXE3;	GO:0019233~sensory perception of pain	7	53	13.2075471698113	0.00352394257850963	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	CYP1A1; CYP2E1; CYP3A5;	GO:0002933~lipid hydroxylation	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	TH; NHLH2; MAPK8IP2;	GO:0007617~mating behavior	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	CYP1A1; TH; LCN2;	GO:0009635~response to herbicide	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	IDO1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	EDN1; NMB; EDN3;	GO:0046887~positive regulation of hormone secretion	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	AR; ID4; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	IL33; CX3CL1; IL34;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	AQP1; RHCG; RHBG;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	PLA2G10; MIF; PLA2R1;	GO:0090238~positive regulation of arachidonic acid secretion	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	ANXA8; SPINK6; SPINK5;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	CCK; GJA1; NPAS2;	GO:2000987~positive regulation of behavioral fear response	3	7	42.8571428571429	0.00360987246971289	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	JUP; FUT1; EPHA1; EMP2; CX3CL1;	GO:0001954~positive regulation of cell-matrix adhesion	5	27	18.5185185185185	0.00371970933397492	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	GABRR1; GABRB2; GABRA4; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	5	27	18.5185185185185	0.00371970933397492	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	ADCYAP1; ADCYAP1R1; DEFB1; ADGRG6; PCLO;	GO:0019933~cAMP-mediated signaling	5	27	18.5185185185185	0.00371970933397492	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	CTNND1; PLEKHA7; CDH19; CDH17; CDH8;	GO:0044331~cell-cell adhesion mediated by cadherin	5	27	18.5185185185185	0.00371970933397492	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	EDN1; MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.00374115985315038	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	CXCL10; BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	4	16	25	0.00374115985315038	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	GLI2; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	4	16	25	0.00374115985315038	0.0566039163431811	1	1	0.999999575044437	0.999999575044437	0.492523022137535
down	BMP2; BMP7; WNT4; FOXF2; AKNAD1; FAM83D;	GO:0001837~epithelial to mesenchymal transition	6	40	15	0.00386558458162312	0.0579665883484284	1	1	0.999999575044437	0.999999575044437	0.504379928471323
down	HMGCS2; HMGCS1; DHCR24; NSDHL; ACAT2; NPC1L1;	GO:0006695~cholesterol biosynthetic process	6	40	15	0.00386558458162312	0.0579665883484284	1	1	0.999999575044437	0.999999575044437	0.504379928471323
down	CXCL11; CXCL10; CX3CL1; CCL22; CCL11; CXCL9; CCL17; CCL19;	GO:0070098~chemokine-mediated signaling pathway	8	70	11.4285714285714	0.00418536370410871	0.0619360400774684	1	1	0.999999575044437	0.999999575044437	0.538918993753709
down	KRT6A; KRT16; SERPINB5; CA9;	GO:0002009~morphogenesis of an epithelium	4	17	23.5294117647059	0.00450201283930984	0.0657566723802226	1	1	0.999999575044437	0.999999575044437	0.572163148748568
down	ALOX15B; PLA2G10; PLA2G2A; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	4	17	23.5294117647059	0.00450201283930984	0.0657566723802226	1	1	0.999999575044437	0.999999575044437	0.572163148748568
down	CTSV; AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.00450201283930984	0.0657566723802226	1	1	0.999999575044437	0.999999575044437	0.572163148748568
down	SORBS2; MSMB; TM4SF1; CRYBA2; KRTDAP; TCHH; RAD51AP2; KRT24; PRICKLE4; TTC39A; GGT6; SBSN; IGFL2; USP53; KRT27; TMPRSS11B; UNC93A; IL22RA1; FIBIN; NKX2-3; GIPC2; TMEM54; TMEM125; GPR87; GSDMC; GCOM2; UACA; PLA2G2F; RNF39; CCM2L; ETNK2; CGN; PSORS1C2; LINC01558;	GO:0008150~biological_process	34	603	5.63847429519071	0.00460911998678115	0.0670309087732742	1	1	0.999999575044437	0.999999575044437	0.583250557531706
down	AKR1C1; AKR1C3; AKR1C2;	GO:0008207~C21-steroid hormone metabolic process	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	DLG2; MAGI3; TJP2;	GO:0046710~GDP metabolic process	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	CRABP2; EFNA5; LPAR3;	GO:0048672~positive regulation of collateral sprouting	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	CYP1A1; MAOB; DUOX2;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	COBL; PLS3; PLS1;	GO:0051639~actin filament network formation	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	DKK1; C1QC; CX3CL1;	GO:0098883~synapse pruning	3	8	37.5	0.00484245388622528	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	BMP7; ITGA8; IRX3; SOX17; ROBO2;	GO:0001656~metanephros development	5	29	17.2413793103448	0.00486828885342083	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	FOXN1; CRISP3; CX3CL1; MST1R; CXCL9; TPSAB1; DUOX2; NOX5;	GO:0006952~defense response	8	72	11.1111111111111	0.00488557145728408	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
down	CTSV; KRT20; AKR1C3; WNT4; CADPS2; MFSD2A; WNT2B; MYH13;	GO:0009267~cellular response to starvation	8	72	11.1111111111111	0.00488557145728408	0.067835053896611	1	1	0.999999575044437	0.999999575044437	0.59024759964416
up	TRPM2; LYN; GATA1; AXL; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	7	12	58.3333333333333	0.00492189857789371	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	PPL; SCEL; CCNB1; IGFBP2; BDKRB1; LRP11; PIEZO2;	GO:0009612~response to mechanical stimulus	7	57	12.280701754386	0.00506099690614281	0.0696971573931667	1	1	0.999999575044437	0.999999575044437	0.606450168316194
down	DLX3; GLI2; BMP2; BMP7; AMTN; SOSTDC1; NKX2-3;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00506099690614281	0.0696971573931667	1	1	0.999999575044437	0.999999575044437	0.606450168316194
down	TYRO3; KDR; ROR1; ERBB3; EPHA1; EPHA2; MST1R; FGFR3;	GO:0033674~positive regulation of kinase activity	8	73	10.958904109589	0.00526763415207743	0.0717704819057736	1	1	0.999999575044437	0.999999575044437	0.624490617118886
down	RGS5; RGS11; ADCYAP1; GNG4; KCTD8; HOMER2;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	6	43	13.953488372093	0.00530911505192122	0.0717704819057736	1	1	0.999999575044437	0.999999575044437	0.624490617118886
down	CTSV; CRYAB; EDN1; TH;	GO:0010259~multicellular organism aging	4	18	22.2222222222222	0.00536045093072168	0.0717704819057736	1	1	0.999999575044437	0.999999575044437	0.624490617118886
down	EDN1; EDN2; NPNT; NMU;	GO:0045987~positive regulation of smooth muscle contraction	4	18	22.2222222222222	0.00536045093072168	0.0717704819057736	1	1	0.999999575044437	0.999999575044437	0.624490617118886
down	CXCL10; S100A7; CXCL17; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.00536045093072168	0.0717704819057736	1	1	0.999999575044437	0.999999575044437	0.624490617118886
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; LYN; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	8	16	50	0.00541903719047432	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	ABO; FUT1; FUT3; FUT6; FUT2; ST6GAL2; B3GNT6; B3GNT3; B3GALT5;	GO:0006486~protein glycosylation	9	90	10	0.00549663658176114	0.0731408941246822	1	1	0.999999575044437	0.999999575044437	0.636414872739979
down	EDN1; BMP7; HOXD3; LUM; PITX1; HES5; IL17F;	GO:0051216~cartilage development	7	58	12.0689655172414	0.00551362356704377	0.0731408941246822	1	1	0.999999575044437	0.999999575044437	0.636414872739979
down	MT1X; MT1A; MT1H; MT1G; MT1M;	GO:0006882~cellular zinc ion homeostasis	5	30	16.6666666666667	0.00552783876757379	0.0731408941246822	1	1	0.999999575044437	0.999999575044437	0.636414872739979
down	ANXA1; CX3CL1; CCL17; CCL19; CCL22; CCL11;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.00586789786401998	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
up	TNF; APOA2; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	5	6	83.3333333333333	0.00622115579292193	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	GLI2; HOXB1; SOSTDC1; GRHL3; SHROOM3;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.00624798273032368	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	DKK1; PAX9; DLX5; STRA6; CRISPLD1;	GO:0060325~face morphogenesis	5	31	16.1290322580645	0.00624798273032368	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	SFN; KRT2; EXPH5;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.00629932933999244	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	FUT1; FUT6; FUT2;	GO:0042355~L-fucose catabolic process	3	9	33.3333333333333	0.00629932933999244	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.00629932933999244	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	ELN; NPPC; PDE1A;	GO:0048660~regulation of smooth muscle cell proliferation	3	9	33.3333333333333	0.00629932933999244	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	DLX3; DLX5; DLG2; LRRC1;	GO:0009790~embryo development	4	19	21.0526315789474	0.00632170737741022	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	UNC13B; NTF4; GABRB2; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.00632170737741022	0.0770015909436177	1	1	0.999999575044437	0.999999575044437	0.670007637828713
down	RHOD; AIF1L; RND3; PLS3; PLS1; BAIAP2L2;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.00646833765498889	0.0781531411212641	1	1	0.999999575044437	0.999999575044437	0.680027527092184
down	EPHA2; APLNR; SOX18; KDR; FOXF1; SOX17; TMEM100;	GO:0001570~vasculogenesis	7	60	11.6666666666667	0.00650890120185987	0.0781531411212641	1	1	0.999999575044437	0.999999575044437	0.680027527092184
down	FGF1; EDN1; EDN3; MIF; MST1R; TPD52L1; EPGN;	GO:0043406~positive regulation of MAP kinase activity	7	60	11.6666666666667	0.00650890120185987	0.0781531411212641	1	1	0.999999575044437	0.999999575044437	0.680027527092184
down	CTSV; BCHE; SCGB1A1; IGFBP2; AGXT; ALDH3A1; HSD11B2;	GO:0051384~response to glucocorticoid	7	60	11.6666666666667	0.00650890120185987	0.0781531411212641	1	1	0.999999575044437	0.999999575044437	0.680027527092184
up	CD74; CD19; FCGR2B; PRKCD; TCIRG1; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	7	13	53.8461538461538	0.00679502046998348	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	SMIM22; EFNA5; GRHL3; FZD10; ARHGAP40; RND3; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	8	77	10.3896103896104	0.00702795470352147	0.0826627527620285	1	1	0.999999575044437	0.999999575044437	0.719266641582244
down	SCNN1B; SCNN1G; AMN; UGT1A7; ATP6V0A4;	GO:0007588~excretion	5	32	15.625	0.00703147896938416	0.0826627527620285	1	1	0.999999575044437	0.999999575044437	0.719266641582244
down	TJP1; CNN3; MYH14; EPB41L4B; LIMCH1;	GO:0031032~actomyosin structure organization	5	32	15.625	0.00703147896938416	0.0826627527620285	1	1	0.999999575044437	0.999999575044437	0.719266641582244
down	FGF1; ADRA2C; NTF3; IL18; DYNAP;	GO:0032148~activation of protein kinase B activity	5	32	15.625	0.00703147896938416	0.0826627527620285	1	1	0.999999575044437	0.999999575044437	0.719266641582244
down	EFNA1; EPHA2; ID1; EMP2; GPNMB;	GO:0045765~regulation of angiogenesis	5	32	15.625	0.00703147896938416	0.0826627527620285	1	1	0.999999575044437	0.999999575044437	0.719266641582244
down	ZBTB7C; SULT2B1; ALOX15B; GJB6; GAS8; TFF1; BCHE; AR; BMP2; NPPC; AZGP1; S100A11; HNF4A; CDKN2B; SLURP1; GPLD1; DPT; FGFBP1; GPNMB; DHCR24; BNIPL; CAMK2N1; TFAP2B; SOX7;	GO:0008285~negative regulation of cell population proliferation	24	396	6.06060606060606	0.00709601964876971	0.0827460349356819	1	1	0.999999575044437	0.999999575044437	0.719991297940106
down	DKK1; LRAT; GJA1; IGFBP2; GJB2; AQP3;	GO:0032526~response to retinoic acid	6	46	13.0434782608696	0.00711213696838997	0.0827460349356819	1	1	0.999999575044437	0.999999575044437	0.719991297940106
down	GJB6; CXCL14; BMP2; GJB2; ROR1; ADGRV1;	GO:0048839~inner ear development	6	46	13.0434782608696	0.00711213696838997	0.0827460349356819	1	1	0.999999575044437	0.999999575044437	0.719991297940106
down	CYP1A1; CYP2C9; CYP3A5; UGT1A1;	GO:0008210~estrogen metabolic process	4	20	20	0.00739075751835361	0.0851072213888228	1	1	0.999999575044437	0.999999575044437	0.740536496273741
down	EDN1; EDN3; EDN2; NMU;	GO:0010460~positive regulation of heart rate	4	20	20	0.00739075751835361	0.0851072213888228	1	1	0.999999575044437	0.999999575044437	0.740536496273741
down	TFF1; TH; GJA1; BMP7; GNAI1; ANXA1;	GO:0043434~response to peptide hormone	6	47	12.7659574468085	0.00780098664442397	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	FGF1; PTN; BTC; MACC1; GAREM1; GKN1;	GO:0051781~positive regulation of cell division	6	47	12.7659574468085	0.00780098664442397	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	EDN1; ERBB3; TYRO3; NYAP1; PREX2;	GO:0014065~phosphatidylinositol 3-kinase signaling	5	33	15.1515151515152	0.00788103012312813	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	ADCYAP1; HNF1B; FAM3B; PCLO; ANXA1;	GO:0030073~insulin secretion	5	33	15.1515151515152	0.00788103012312813	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	AQP1; AQP5; PAX9; AQP3; TUFT1;	GO:0042476~odontogenesis	5	33	15.1515151515152	0.00788103012312813	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	EDN1; EDN3; EDN2;	GO:0014824~artery smooth muscle contraction	3	10	30	0.00799000410708484	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	EMP1; EMP2; LPAR3;	GO:0032060~bleb assembly	3	10	30	0.00799000410708484	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	AKR1C3; AKR1C2; AKR1C1;	GO:0042448~progesterone metabolic process	3	10	30	0.00799000410708484	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	PLA2G10; MIF; SLC7A2;	GO:0043030~regulation of macrophage activation	3	10	30	0.00799000410708484	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	DLG2; MAGI3; TJP2;	GO:0046037~GMP metabolic process	3	10	30	0.00799000410708484	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	CLDN1; EDN1; FIBIN;	GO:0071548~response to dexamethasone	3	10	30	0.00799000410708484	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.00799000410708484	0.0880989341741969	1	1	0.999999575044437	0.999999575044437	0.766568041749966
down	CHRNB4; CLDN10; SLC26A9; SLC5A8; SLC5A5; WNK4; SLC25A10; SLC9A2; PLLP;	GO:0006811~ion transport	9	96	9.375	0.00802013276980751	0.0881430878349529	1	1	0.999999575044437	0.999999575044437	0.76695223238268
down	CYP1A1; TH; PLA2G4D; ACOT11; MECR; UGT1A8; FA2H;	GO:0006631~fatty acid metabolic process	7	63	11.1111111111111	0.00824411882232601	0.0900183071408672	1	1	0.999999575044437	0.999999575044437	0.783268924572669
down	SPTBN2; ADGRF1; SLITRK6; PCDHB10; PCDHB5; PCDHB11; PCLO;	GO:0007416~synapse assembly	7	63	11.1111111111111	0.00824411882232601	0.0900183071408672	1	1	0.999999575044437	0.999999575044437	0.783268924572669
down	GJA1; ADCYAP1; ACADL; ESRRG; LCN2; FABP5; IL18; DIO2; ELOVL6;	GO:0120162~positive regulation of cold-induced thermogenesis	9	97	9.27835051546392	0.00851451641651624	0.0921113158706398	1	1	0.999999575044437	0.999999575044437	0.801480650042298
down	SNCG; CSTB; HOXD9; NTF4; PREX2; SLITRK6;	GO:0008344~adult locomotory behavior	6	48	12.5	0.00853656225073385	0.0921113158706398	1	1	0.999999575044437	0.999999575044437	0.801480650042298
down	EFNA1; EPHA1; ITGA8; TYRO3; SRCIN1; LAMB4;	GO:0034446~substrate adhesion-dependent cell spreading	6	48	12.5	0.00853656225073385	0.0921113158706398	1	1	0.999999575044437	0.999999575044437	0.801480650042298
down	PLPP2; FUT3; FUT6; ORMDL2;	GO:0006672~ceramide metabolic process	4	21	19.047619047619	0.00857230384806784	0.0921113158706398	1	1	0.999999575044437	0.999999575044437	0.801480650042298
down	CLDN1; TJP1; OCLN; MARVELD2;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.00857230384806784	0.0921113158706398	1	1	0.999999575044437	0.999999575044437	0.801480650042298
down	FOXP2; EDN2; FOXF1; ABCA12; STRA6;	GO:0048286~lung alveolus development	5	34	14.7058823529412	0.00879927562846983	0.093951759400181	1	1	0.999999575044437	0.999999575044437	0.817494750617024
down	MAP2; VLDLR; MAPK8IP2; PREX2; DCDC2;	GO:0048813~dendrite morphogenesis	5	34	14.7058823529412	0.00879927562846983	0.093951759400181	1	1	0.999999575044437	0.999999575044437	0.817494750617024
down	C2CD4B; FUT1; FUT2; IL18; LMO7; SPINK5;	GO:0030155~regulation of cell adhesion	6	49	12.2448979591837	0.00932052060038246	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	HNF1B; NR0B2; CIART; NPAS2; LGR4; ID4; ID1;	GO:0032922~circadian regulation of gene expression	7	65	10.7692307692308	0.00957584865136962	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
up	LPXN; FCGR2B; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	5	7	71.4285714285714	0.00961710009574457	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	KLK8; BRINP1; CIDEA; EMP1; EMP2;	GO:0008219~cell death	5	35	14.2857142857143	0.00978878459861932	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	EDN2; NMU; IRX3; MFSD2A; MRAP2;	GO:0097009~energy homeostasis	5	35	14.2857142857143	0.00978878459861932	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	CHP2; RASAL1; EDN1; AKR1C3; GPLD1; ACER1; ADGRV1; SYT8;	GO:0071277~cellular response to calcium ion	8	82	9.75609756097561	0.00981257312449091	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
up	TAL1; SOX9; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	4	4	100	0.00982506660841209	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	CIDEA; EDN2; ACADL; NMU;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.00987076386386154	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	TFF1; CYP1A1; TH; LRP11;	GO:0035902~response to immobilization stress	4	22	18.1818181818182	0.00987076386386154	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	CCNB1; PTN; TM4SF4; KLK6;	GO:0042246~tissue regeneration	4	22	18.1818181818182	0.00987076386386154	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	CSTA; CSTB; SERPINB3; CAMK2N1;	GO:0045861~negative regulation of proteolysis	4	22	18.1818181818182	0.00987076386386154	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	GSTA4; HPGDS; GSTA1; GSTM3;	GO:1901687~glutathione derivative biosynthetic process	4	22	18.1818181818182	0.00987076386386154	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	MAPT; MAP2; CAMSAP3;	GO:0031113~regulation of microtubule polymerization	3	11	27.2727272727273	0.0099222700571181	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	KLK8; KRT2; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.0099222700571181	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	DSP; PLEKHA7; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	3	11	27.2727272727273	0.0099222700571181	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	MAPT; PTN; SCTR; CX3CL1; FGF14; PLK2;	GO:0048167~regulation of synaptic plasticity	6	50	12	0.0101544963665969	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	EGFL8; TFAP2B; ROR1; HNF4A; HNF4G; TFAP2C;	GO:0048856~anatomical structure development	6	50	12	0.0101544963665969	0.0969291199316516	1	1	0.999999575044437	0.999999575044437	0.843401414001625
down	ARHGAP32; RGS5; RGS11; ARHGEF15; RASAL1; ADCYAP1; CCL11; WNT4; S100A10; ARHGAP40; ALS2CL; PREX2; GRHL3; AGAP11; CCL19; RASAL2; FZD10; CX3CL1; CCL17; CCL22;	GO:0043547~positive regulation of GTPase activity	20	322	6.2111801242236	0.0103885538467618	0.0984578108959957	1	1	0.999999575044437	0.999999575044437	0.856702887509365
down	CXCL10; EDN3; ELN; BDKRB2; MEOX2;	GO:0008015~blood circulation	5	36	13.8888888888889	0.0108520491914372	0.101707816588637	1	1	0.999999575044437	0.999999575044437	0.884981895908694
down	CXCL10; HSPA2; CDH8; LRP11; ACOT11;	GO:0009409~response to cold	5	36	13.8888888888889	0.0108520491914372	0.101707816588637	1	1	0.999999575044437	0.999999575044437	0.884981895908694
down	GAS8; FOXA1; TTC23; DCDC2; INTU;	GO:0045880~positive regulation of smoothened signaling pathway	5	36	13.8888888888889	0.0108520491914372	0.101707816588637	1	1	0.999999575044437	0.999999575044437	0.884981895908694
down	CTSV; GJA1; HNF1B; HNF4A; GYS2; GPLD1; NR0B2;	GO:0009749~response to glucose	7	67	10.4477611940298	0.0110581221687945	0.103352089189786	1	1	0.999999575044437	0.999999575044437	0.899289070448103
down	RHOD; EFNA5; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	4	23	17.3913043478261	0.0112902604554206	0.105230217614887	1	1	0.999999575044437	0.999999575044437	0.91563107551865
down	ZBTB7C; BMP2; KLF5; MEDAG; CDS1; RARRES2;	GO:0045600~positive regulation of fat cell differentiation	6	52	11.5384615384615	0.0119789085648782	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
down	ARHGEF15; EPHA1; WNT4; S100A10; SYNPO2L; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	6	52	11.5384615384615	0.0119789085648782	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
down	DLX3; GJB3; PLAC1; ETNK2; PHLDA2;	GO:0001890~placenta development	5	37	13.5135135135135	0.0119914784688567	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
up	TNF; APOA2; CD74; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	7	15	46.6666666666667	0.0120480679304169	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	DKK1; SOX7; SOX17;	GO:0001706~endoderm formation	3	12	25	0.0121023359344137	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.0121023359344137	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
down	ADH1B; ADH1C; ADH7;	GO:0006069~ethanol oxidation	3	12	25	0.0121023359344137	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
down	HYKK; CRYM; SLC25A21;	GO:0006554~lysine catabolic process	3	12	25	0.0121023359344137	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
down	CHST9; DIO2; DUOX2;	GO:0042446~hormone biosynthetic process	3	12	25	0.0121023359344137	0.110062753214856	1	1	0.999999575044437	0.999999575044437	0.957680021811586
down	EFNA1; FOXA1; VASN; OVOL2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	4	24	16.6666666666667	0.0128346146143186	0.115477305889896	1	1	0.999999575044437	0.999999575044437	1
down	NPPC; EDNRB; AQP1; GUCY1B2;	GO:0019934~cGMP-mediated signaling	4	24	16.6666666666667	0.0128346146143186	0.115477305889896	1	1	0.999999575044437	0.999999575044437	1
down	CX3CL1; CXCL10; CXCL11; CXCL9;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0128346146143186	0.115477305889896	1	1	0.999999575044437	0.999999575044437	1
down	CYP1A1; CYP2E1; CYP2C9; ELOVL6;	GO:0042759~long-chain fatty acid biosynthetic process	4	24	16.6666666666667	0.0128346146143186	0.115477305889896	1	1	0.999999575044437	0.999999575044437	1
down	ASTN1; HPGDS; TH; CHRNB4; NOVA1; SLURP1; PAK6; PAK5;	GO:0007626~locomotory behavior	8	87	9.19540229885057	0.0133432472775357	0.119734351900014	1	1	0.999999575044437	0.999999575044437	1
down	SASH1; FGF1; EDN1; FUT1; KDR; GPLD1;	GO:0010595~positive regulation of endothelial cell migration	6	54	11.1111111111111	0.0140223115744949	0.124011026841904	1	1	0.999999575044437	0.999999575044437	1
up	TNF; IFNG; IFNGR1; LRPAP1; MYOCD;	GO:1900222~negative regulation of amyloid-beta clearance	5	8	62.5	0.0140981200709556	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	BMP2; BMP7; PTN; WNT4; ADGRV1;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.0145080184318962	0.124011026841904	1	1	0.999999575044437	0.999999575044437	1
down	CPZ; CPXM2; CPE;	GO:0006518~peptide metabolic process	3	13	23.0769230769231	0.0145349500073527	0.124011026841904	1	1	0.999999575044437	0.999999575044437	1
down	NQO1; NOS2; SLC7A2;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.0145349500073527	0.124011026841904	1	1	0.999999575044437	0.999999575044437	1
down	ID1; CX3CL1; SYNPO2L;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.0145349500073527	0.124011026841904	1	1	0.999999575044437	0.999999575044437	1
down	CXCL10; PTN; EPHA2; EFNA3; ECSCR; IL17F; SPINK5; PLK2;	GO:0016525~negative regulation of angiogenesis	8	89	8.98876404494382	0.0149873928296687	0.124244381836123	1	1	0.999999575044437	0.999999575044437	1
up	IRGM; LTF; RNASE2; RNASE3; DEFA4; SELP; AZU1; GSDMD; PRB3; FCN2; LYPD8; RNASE6; OPTN; TLR9; PYCARD; LYZL6; BPI; CAMP; TNFRSF14; DEFA3;	GO:0050829~defense response to Gram-negative bacterium	20	80	25	0.0151065372169845	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	SYCN; LGI3; NKD2; SRCIN1; SYTL5; RAB25; CADPS2; STX19;	GO:0006887~exocytosis	8	90	8.88888888888889	0.0158623595971586	0.131078525100586	1	1	0.999999575044437	0.999999575044437	1
down	PIGR; TF; HSPB1; AZGP1; ZG16B;	GO:0001895~retina homeostasis	5	40	12.5	0.0158894833331772	0.131078525100586	1	1	0.999999575044437	0.999999575044437	1
up	DRD5; AVPR1A; AVPR1B; AVPR2;	GO:0001992~regulation of systemic arterial blood pressure by vasopressin	4	5	80	0.0160139621337856	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	GJB3; GJB5; TRIP10; CCL19;	GO:0007154~cell communication	4	26	15.3846153846154	0.0163116409541875	0.134232869705923	1	1	0.999999575044437	0.999999575044437	1
up	TNFSF11; TNFRSF13B; AIM2; TNFSF12; ST18; TNFSF13; TNF; TNFRSF1A; PSMB8; PSMB9; TNFRSF8; CD40LG; CD70; PSMB10; TNFRSF4; LIMS1; PSMB3; TNFRSF17; PSME1; TRADD; COMMD7; PSMA8; PSMF1; TNFRSF14; CDIP1; PYCARD; TNFRSF18;	GO:0033209~tumor necrosis factor-mediated signaling pathway	27	120	22.5	0.0165285036658197	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	TNFSF12; PML; TNFSF10; BID; FADD; DEDD2; RBCK1; ITM2C; PYCARD;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	9	25	36	0.016641957395309	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	SFN; SLURP1; INTU;	GO:0010839~negative regulation of keratinocyte proliferation	3	14	21.4285714285714	0.0172235154775547	0.1393576528088	1	1	0.999999575044437	0.999999575044437	1
down	CXCL10; PTN; USP53;	GO:0010996~response to auditory stimulus	3	14	21.4285714285714	0.0172235154775547	0.1393576528088	1	1	0.999999575044437	0.999999575044437	1
down	FOXA1; WNT4; KLK6;	GO:0042445~hormone metabolic process	3	14	21.4285714285714	0.0172235154775547	0.1393576528088	1	1	0.999999575044437	0.999999575044437	1
down	FOXP2; ITGA8; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.0172235154775547	0.1393576528088	1	1	0.999999575044437	0.999999575044437	1
down	SCNN1A; SCNN1B; SCNN1G;	GO:0050909~sensory perception of taste	3	14	21.4285714285714	0.0172235154775547	0.1393576528088	1	1	0.999999575044437	0.999999575044437	1
down	CLDN1; TJP1; TJP2;	GO:0090557~establishment of endothelial intestinal barrier	3	14	21.4285714285714	0.0172235154775547	0.1393576528088	1	1	0.999999575044437	0.999999575044437	1
down	GJA1; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.0172235154775547	0.1393576528088	1	1	0.999999575044437	0.999999575044437	1
down	DHCR24; DUOXA1; DUOXA2; PHYHIP; WNK4; SLC9A2; PARD3;	GO:0008104~protein localization	7	74	9.45945945945946	0.0175587644791499	0.141392055734253	1	1	0.999999575044437	0.999999575044437	1
down	CXCL14; EPHA2; CX3CL1; ARHGEF16; SAA2; SAA1; DEFB4A;	GO:0060326~cell chemotaxis	7	74	9.45945945945946	0.0175587644791499	0.141392055734253	1	1	0.999999575044437	0.999999575044437	1
down	GLI2; HOXC10; HOXD9; HOXC9;	GO:0009954~proximal/distal pattern formation	4	27	14.8148148148148	0.0182504084298418	0.145571815702805	1	1	0.999999575044437	0.999999575044437	1
down	TJP1; WWC1; TJP2; AMOTL2;	GO:0035329~hippo signaling	4	27	14.8148148148148	0.0182504084298418	0.145571815702805	1	1	0.999999575044437	0.999999575044437	1
down	ANXA1; HSPB1; MT1G; KDR;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	4	27	14.8148148148148	0.0182504084298418	0.145571815702805	1	1	0.999999575044437	0.999999575044437	1
down	CA12; AQP1; CA9; CYB5R2; SLC26A9;	GO:0015701~bicarbonate transport	5	42	11.9047619047619	0.0189089242132242	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	DKK1; ADH7; LYPD6; GPIHBP1; DKK4;	GO:2000272~negative regulation of signaling receptor activity	5	42	11.9047619047619	0.0189089242132242	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
up	IRGM; ACOD1; CD14; VIM; CSF3; TFPI; CEBPB; TBXA2R; IL10; AXL; CCR5; HAMP; IRF8; CEBPE; CARD16; LILRB2; TNIP2; LILRB1; NLRP7; GHSR; LITAF; MYD88; PYCARD; DEFA4; PF4; PDCD1LG2; PF4V1; CD80; NR1H2; NR1I2; CXCL3; DEFA3; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	34	163	20.8588957055215	0.0195439482502192	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	NFASC; PIGR; SLPI; CSTB; S100A8; MIF; JUP; DSP; AGA; SERPINB3; CHRNB4; S100A7; S100A11; PRSS3; CEACAM6; CRISP3; LCN2; FABP5; DSG1; PLD1; PKP1; FLG2; HRNR; GGH; SERPINB12; CALML5;	GO:0043312~neutrophil degranulation	26	483	5.38302277432712	0.019781124518115	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
up	HLA-B; HLA-H; HLA-A; HLA-C; B2M;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	5	9	55.5555555555556	0.0197919163295452	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	CLEC3B; BMP7; NPPC; STC1; GPLD1; ECM1; ATP6V0A4;	GO:0001503~ossification	7	76	9.21052631578947	0.0198258085541155	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	SOX18; SOX17; NDRG4;	GO:0035050~embryonic heart tube development	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	TH; BMP7; FOXF2;	GO:0048596~embryonic camera-type eye morphogenesis	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	BRINP1; SRPX2; MYH14;	GO:0071625~vocalization behavior	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	COBL; EPS8L1; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	ID1; KLF5; KLF15;	GO:1901653~cellular response to peptide	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	NIPAL4; NIPAL1; ZDHHC13;	GO:1903830~magnesium ion transmembrane transport	3	15	20	0.0201701990210139	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	EDN1; CCK; BDKRB1; PARD3;	GO:0007205~protein kinase C-activating G protein-coupled receptor signaling pathway	4	28	14.2857142857143	0.0203262225864058	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	EDN1; EDN3; BTC; EPGN;	GO:0045840~positive regulation of mitotic nuclear division	4	28	14.2857142857143	0.0203262225864058	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	CTH; WNT4; CX3CL1; MAPK8IP2;	GO:2001234~negative regulation of apoptotic signaling pathway	4	28	14.2857142857143	0.0203262225864058	0.148935607699234	1	1	0.999999575044437	0.999999575044437	1
down	MMP3; MMP7; COL15A1; MMP12; KLK6;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.0205506271893716	0.149434948570991	1	1	0.999999575044437	0.999999575044437	1
down	EPS8L1; EPS8L2; RHOD; CDC42EP5; RHOV; C15orf62; RND3;	GO:0007266~Rho protein signal transduction	7	77	9.09090909090909	0.0210325712990791	0.152610528092673	1	1	0.999999575044437	0.999999575044437	1
up	LILRA5; IFNG; ORM1; LPL; IFNGR1; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	8	22	36.3636363636364	0.0224003042392406	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	PHGDH; EPHA2; HES5; INTU;	GO:0021915~neural tube development	4	29	13.7931034482759	0.022541352976008	0.162857655120024	1	1	0.999999575044437	0.999999575044437	1
down	IL33; SCGB1A1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.022541352976008	0.162857655120024	1	1	0.999999575044437	0.999999575044437	1
down	CYB5A; OTOP3; OTOP2; ATP6V1C2; SLC2A12; NOX5; ATP6V0A4; NDUFA4L2; SLC9A2;	GO:1902600~proton transmembrane transport	9	116	7.75862068965517	0.0229528682965165	0.165476447932579	1	1	0.999999575044437	0.999999575044437	1
down	AR; RAB25; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.0233760328162775	0.166745739370233	1	1	0.999999575044437	0.999999575044437	1
down	AQP1; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0233760328162775	0.166745739370233	1	1	0.999999575044437	0.999999575044437	1
down	INHA; BMP7; CDKN2B;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.0233760328162775	0.166745739370233	1	1	0.999999575044437	0.999999575044437	1
down	EDN1; NOX5; DUOX2;	GO:0042554~superoxide anion generation	3	16	18.75	0.0233760328162775	0.166745739370233	1	1	0.999999575044437	0.999999575044437	1
down	MMP7; PTN; ANXA1;	GO:0044849~estrous cycle	3	16	18.75	0.0233760328162775	0.166745739370233	1	1	0.999999575044437	0.999999575044437	1
down	FGF1; FGFR3; FGFBP1; ESRP1; ESRP2; FGF22; FLRT1;	GO:0008543~fibroblast growth factor receptor signaling pathway	7	79	8.86075949367089	0.0235971748154147	0.167968075584829	1	1	0.999999575044437	0.999999575044437	1
up	TNFSF11; TCIRG1; ADAMTS5; SNX10;	GO:0044691~tooth eruption	4	6	66.6666666666667	0.0241802539262612	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	ACOD1; CD14; FCGR2B; FAM49B;	GO:0071219~cellular response to molecule of bacterial origin	4	6	66.6666666666667	0.0241802539262612	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	TNF; FAS; FASLG; FADD;	GO:0097527~necroptotic signaling pathway	4	6	66.6666666666667	0.0241802539262612	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	FCGR2B; TMEM176B; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	4	6	66.6666666666667	0.0241802539262612	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	SPI1; RELB; DHRS2; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	7	18	38.8888888888889	0.0246234452051073	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	TMPRSS11D; EDN1; ELN; SFTPA2;	GO:0007585~respiratory gaseous exchange by respiratory system	4	30	13.3333333333333	0.0248977615256831	0.176481191990872	1	1	0.999999575044437	0.999999575044437	1
down	PIGR; PTN; LRRC1; DLG2;	GO:0043113~receptor clustering	4	30	13.3333333333333	0.0248977615256831	0.176481191990872	1	1	0.999999575044437	0.999999575044437	1
up	F8; PF4; GP1BA; LYN; PF4V1; GP9; F2R; PTPN6; CD40LG; FCER1G; GP5; P2RX1; GNA12; PRKCD; TRPC3; DGKK; PIK3R6; PDPN; TREML1; PIK3R5; F2RL3; CLEC1B; AXL;	GO:0030168~platelet activation	23	102	22.5490196078431	0.0249091144029198	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	NKX2-8; FGF1; GLI2; PTN; FOXF1; SIM2; STRA6;	GO:0030324~lung development	7	80	8.75	0.0249567725056897	0.176528617262468	1	1	0.999999575044437	0.999999575044437	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0263076574566963	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.0263076574566963	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0263076574566963	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	HLA-B; CEBPB; LILRB2;	GO:2001198~regulation of dendritic cell differentiation	3	3	100	0.0263076574566963	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	EDN1; LCN2; CCL17; CCL22; CX3CL1; CCL11; CCL19;	GO:0071347~cellular response to interleukin-1	7	81	8.64197530864197	0.0263690239488951	0.177224205641425	1	1	0.999999575044437	0.999999575044437	1
up	PTPN6; ZFP36L2; FCRL3; TLR9; SLAMF8;	GO:0045577~regulation of B cell differentiation	5	10	50	0.0268041002114736	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	DIO2; SLC5A5; DUOX2;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.0268410103979752	0.177224205641425	1	1	0.999999575044437	0.999999575044437	1
down	AQP1; AQP5; AQP3;	GO:0006833~water transport	3	17	17.6470588235294	0.0268410103979752	0.177224205641425	1	1	0.999999575044437	0.999999575044437	1
down	KCNK1; KCNK7; KCNK15;	GO:0030322~stabilization of membrane potential	3	17	17.6470588235294	0.0268410103979752	0.177224205641425	1	1	0.999999575044437	0.999999575044437	1
down	GJA1; EPHA2; LGR4;	GO:0046849~bone remodeling	3	17	17.6470588235294	0.0268410103979752	0.177224205641425	1	1	0.999999575044437	0.999999575044437	1
down	USH1G; HES5; ADGRV1;	GO:0060122~inner ear receptor cell stereocilium organization	3	17	17.6470588235294	0.0268410103979752	0.177224205641425	1	1	0.999999575044437	0.999999575044437	1
up	NTRK1; CCR2; ROR2; TSHZ3; NLGN2; SHANK3; NRXN1; SHANK1;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	8	23	34.7826086956522	0.0270932928744885	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	KRT14; S100A8; TH; GGH;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.0273971063976762	0.180190715371851	1	1	0.999999575044437	0.999999575044437	1
down	PLA2G10; HNF4A; AKR1C1; MALL; IL18; GPIHBP1; CYP39A1;	GO:0042632~cholesterol homeostasis	7	83	8.43373493975904	0.0293546749858278	0.19231587068385	1	1	0.999999575044437	0.999999575044437	1
down	ESYT3; VLDLR; ABCA12; SPNS2; SLCO2A1; GULP1;	GO:0006869~lipid transport	6	65	9.23076923076923	0.0296751734728494	0.194038828095725	1	1	0.999999575044437	0.999999575044437	1
down	DKK1; BMP7; WNT3; MESP2;	GO:0001707~mesoderm formation	4	32	12.5	0.0300407468561203	0.196033873868869	1	1	0.999999575044437	0.999999575044437	1
down	TMPRSS2; CTSE; KLK6;	GO:0016540~protein autoprocessing	3	18	16.6666666666667	0.030564176657756	0.19680063367036	1	1	0.999999575044437	0.999999575044437	1
down	POU3F1; ADGRG6; PARD3;	GO:0022011~myelination in peripheral nervous system	3	18	16.6666666666667	0.030564176657756	0.19680063367036	1	1	0.999999575044437	0.999999575044437	1
down	GLI2; BMP7; HNF1B;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.030564176657756	0.19680063367036	1	1	0.999999575044437	0.999999575044437	1
down	IL18; RAET1G; RAET1E;	GO:0042267~natural killer cell mediated cytotoxicity	3	18	16.6666666666667	0.030564176657756	0.19680063367036	1	1	0.999999575044437	0.999999575044437	1
down	HNF1B; FOXF1; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.030564176657756	0.19680063367036	1	1	0.999999575044437	0.999999575044437	1
down	FGF1; FUT1; TJP1;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.030564176657756	0.19680063367036	1	1	0.999999575044437	0.999999575044437	1
down	CCL22; HSPB1; CYP1A1; CCL11; LCN2; MST1R; CCL19; DUOX2;	GO:0009615~response to virus	8	104	7.69230769230769	0.0322554998112563	0.203517411379109	1	1	0.999999575044437	0.999999575044437	1
up	PF4; BCL3; IL10; IRF8; IRF4; BATF; MYD88; GBP7;	GO:0042832~defense response to protozoan	8	24	33.3333333333333	0.0324257839063574	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	FAM83G; BMP2; BMP7; ID1; DLX5; SOSTDC1; TMEM100;	GO:0030509~BMP signaling pathway	7	85	8.23529411764706	0.032560181506299	0.203517411379109	1	1	0.999999575044437	0.999999575044437	1
up	CCL21; TNFRSF10B; TNFSF11; TNF; LTF; CD74; RHOC; LGALS1; TNFRSF1A; TGM2; F2R; S100A4; NUP62; FASLG; TNFSF10; S100A12; FADD; IKBKE; PRKD1; TRADD; CARD16; CLEC6A; SHISA5; TNIP2; C18orf32; SECTM1; TMEM106A; LITAF; MYD88; RBCK1; TRIM8; SHARPIN; CARD9; NEK6; TLR9; TERF2IP;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	36	183	19.672131147541	0.0326704604154999	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	WNT3; CX3CL1; HES5; HES2;	GO:0050767~regulation of neurogenesis	4	33	12.1212121212121	0.0328297490240896	0.203517411379109	1	1	0.999999575044437	0.999999575044437	1
down	BMP2; BMP7; DLX5; TMEM100;	GO:0071773~cellular response to BMP stimulus	4	33	12.1212121212121	0.0328297490240896	0.203517411379109	1	1	0.999999575044437	0.999999575044437	1
up	SH2B2; F8; F13A1; F10; PLAU; IFNB1; HBD; GP1BA; LYN; F7; TFPI; IRF1; IRF2; GP9; GATA1; F2R; FCER1G; PRKAR2B; GP5; CAPZA2; CAPZB; P2RX1; HBG1; HBG2; GNA12; NFE2; SCUBE1; CD177; F2RL3; P2RX4; VKORC1; EHD1; HMG20B; SERPINA10;	GO:0007596~blood coagulation	34	171	19.8830409356725	0.0330633247643878	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	ARHGAP6; VIL1; AIF1; CORO7; ARPC4; LMOD2; CATIP; MSRB1; MSRB2;	GO:0030041~actin filament polymerization	9	29	31.0344827586207	0.0333629814123199	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	TAZ; PGS1; SLC27A1; PTPMT1;	GO:0032049~cardiolipin biosynthetic process	4	7	57.1428571428571	0.034442595716723	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	MYO5B; MYO1A; MYO5C;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0345437122988823	0.208498184787887	1	1	0.999999575044437	0.999999575044437	1
down	PTN; PTPRZ1; HES5;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.0345437122988823	0.208498184787887	1	1	0.999999575044437	0.999999575044437	1
down	CIDEA; CIDEC; HILPDA;	GO:0034389~lipid droplet organization	3	19	15.7894736842105	0.0345437122988823	0.208498184787887	1	1	0.999999575044437	0.999999575044437	1
up	LEFTY2; F8; F13A1; CFD; TIMP1; KNG1; ORM1; PPBP; PF4; PSAP; LYN; ITGA2B; SELP; VCL; ORM2; TAGLN2; VEGFC; ITIH3; APLP2; STXBP2; LY6G6F; FERMT3; SCCPDH; SCG3; FAM49B; TOR4A;	GO:0002576~platelet degranulation	26	124	20.9677419354839	0.0355360552015425	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	AQP1; TFAP2B; AQP3; MYO5B;	GO:0003091~renal water homeostasis	4	34	11.7647058823529	0.0357648924243026	0.215099370837071	1	1	0.999999575044437	0.999999575044437	1
down	SASH1; DKK1; EDN1; FZD10;	GO:0043507~positive regulation of JUN kinase activity	4	34	11.7647058823529	0.0357648924243026	0.215099370837071	1	1	0.999999575044437	0.999999575044437	1
down	S100A8; CCK; MAPT; XDH; FAM162A; BCL2L10; CASP14;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	7	87	8.04597701149425	0.0359910645282985	0.216074469249963	1	1	0.999999575044437	0.999999575044437	1
down	CCL11; CDC42EP5; NCKAP1; C15orf62; BAIAP2L2;	GO:0030838~positive regulation of actin filament polymerization	5	51	9.80392156862745	0.0370524155083212	0.222051243206173	1	1	0.999999575044437	0.999999575044437	1
down	GJB3; AQP1; WNT3; PTK6; FZD10; BRINP1;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.0374174977460001	0.223841555664901	1	1	0.999999575044437	0.999999575044437	1
down	WNT3; SHROOM3; TFCP2L1; CDH17; CDH8; CDH19; NCKAP1;	GO:0000902~cell morphogenesis	7	88	7.95454545454545	0.0377925954458715	0.225685339883842	1	1	0.999999575044437	0.999999575044437	1
down	GPR37; NMB; CPE; ADCYAP1; NMU; TYRO3; QRFPR; GPR1;	GO:0007218~neuropeptide signaling pathway	8	108	7.40740740740741	0.0385104910572766	0.229566072132952	1	1	0.999999575044437	0.999999575044437	1
down	EPCAM; HNF4A; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.0387770130370766	0.229945068203665	1	1	0.999999575044437	0.999999575044437	1
down	GJA1; ADCYAP1; NPPC;	GO:0097755~positive regulation of blood vessel diameter	3	20	15	0.0387770130370766	0.229945068203665	1	1	0.999999575044437	0.999999575044437	1
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0388466772009748	0.229945068203665	1	1	0.999999575044437	0.999999575044437	1
down	PTPN3; BTC; EPGN; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	4	35	11.4285714285714	0.0388466772009748	0.229945068203665	1	1	0.999999575044437	0.999999575044437	1
up	TYROBP; NTRK1; LYN; LGALS1; AIF1; MAX; BAX; P2RX4; P2RY12;	GO:0048678~response to axon injury	9	30	30	0.0388925269743082	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	BMP7; HNF4A; ESRRG; HNF4G; NR0B2;	GO:0043401~steroid hormone mediated signaling pathway	5	52	9.61538461538462	0.0395535998070977	0.230282318602936	1	1	0.999999575044437	0.999999575044437	1
down	FUT3; PHLDA2; SRCIN1; CAMSAP3; RHOD; RND3; AMOTL2;	GO:0030334~regulation of cell migration	7	89	7.86516853932584	0.0396522865116392	0.230282318602936	1	1	0.999999575044437	0.999999575044437	1
up	FFAR1; CIB2; ADCY5; S1PR4; KNG1; OXT; CALCA; CD55; EDNRA; F2R; AVPR1A; GLP1R; AVPR1B; C1QTNF1; PROK2; GPR35; TRPC5; PTGDR; ADRA1D; CCR10; TBXA2R; CXCR3; CCR8; CCR6; CCR5; CXCR5; PTGIR; CCR2; PTGFR; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	30	150	20	0.040686952842808	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	SOX15; INHA; AKR1C3; WNT4; HMGCS1; TFAP2C; WNT2B;	GO:0008584~male gonad development	7	90	7.77777777777778	0.0415706671311772	0.232602704644431	1	1	0.999999575044437	0.999999575044437	1
up	OXT; CRHBP; AVPR1A;	GO:0002125~maternal aggressive behavior	3	4	75	0.0419674672114394	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	HLA-DRA; HLA-DMA; HLA-DMB;	GO:0002503~peptide antigen assembly with MHC class II protein complex	3	4	75	0.0419674672114394	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	F10; F7; TFPI;	GO:0007598~blood coagulation, extrinsic pathway	3	4	75	0.0419674672114394	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	PFN1; SHANK3; SHANK1;	GO:0032232~negative regulation of actin filament bundle assembly	3	4	75	0.0419674672114394	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	HLA-A; CLEC4A; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.0419674672114394	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0419674672114394	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	BMP10; MYLK3; PROX1;	GO:0060298~positive regulation of sarcomere organization	3	4	75	0.0419674672114394	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	HES5; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	4	36	11.1111111111111	0.0420753319344138	0.233932437498708	1	1	0.999999575044437	0.999999575044437	1
down	AR; EDN3; BTC; SOX17;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.0420753319344138	0.233932437498708	1	1	0.999999575044437	0.999999575044437	1
down	PARD3; PARD6G; RHOD; RND3; RHOV;	GO:0007163~establishment or maintenance of cell polarity	5	53	9.43396226415094	0.0421549857733298	0.233932437498708	1	1	0.999999575044437	0.999999575044437	1
down	IL33; ADCYAP1; RAB7B; IL1RL2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	5	53	9.43396226415094	0.0421549857733298	0.233932437498708	1	1	0.999999575044437	0.999999575044437	1
down	AGR2; EPHA2; PLS1; ARHGEF16; NKD2;	GO:1903078~positive regulation of protein localization to plasma membrane	5	53	9.43396226415094	0.0421549857733298	0.233932437498708	1	1	0.999999575044437	0.999999575044437	1
down	KDR; GPLD1; CLEC14A;	GO:0002042~cell migration involved in sprouting angiogenesis	3	21	14.2857142857143	0.0432607638254674	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	SCEL; CAMSAP3; STOX2;	GO:0009792~embryo development ending in birth or egg hatching	3	21	14.2857142857143	0.0432607638254674	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	EDN3; EDNRB; OCA2;	GO:0030318~melanocyte differentiation	3	21	14.2857142857143	0.0432607638254674	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	CYP1A1; HSD11B2; GAST;	GO:0032094~response to food	3	21	14.2857142857143	0.0432607638254674	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	FOXN1; TREH; TH; BMP2; ELN; PHLDA2; LAMB4; EGFLAM;	GO:0009887~animal organ morphogenesis	8	111	7.20720720720721	0.0437008984430149	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
up	SOCS2; SOCS1; IFNG; CCR2; IFNAR2; NMI; IFNL1; IFNL2; IL31RA;	GO:0007259~receptor signaling pathway via JAK-STAT	9	31	29.0322580645161	0.0450121236801303	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	HLA-C; HLA-A; HLA-B; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	5	12	41.6666666666667	0.0450814718301552	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	HLA-B; HLA-A; HLA-C; HLA-H; FCGRT;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	5	12	41.6666666666667	0.0450814718301552	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	ITGB4; LAMB3; LAMC2; LAMA3; COL17A1;	GO:0031581~hemidesmosome assembly	5	12	41.6666666666667	0.0450814718301552	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	HEXB; GLB1; GALNS; PRELP; OMD;	GO:0042340~keratan sulfate catabolic process	5	12	41.6666666666667	0.0450814718301552	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	IL2RA; LYN; CTLA4; FCGR2B; FCRLB;	GO:0050777~negative regulation of immune response	5	12	41.6666666666667	0.0450814718301552	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	EPCAM; BMP7; NPNT; ROBO2;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.0454508219606597	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	GSTA4; GSTA1; GSTM3; HPGDS;	GO:0006749~glutathione metabolic process	4	37	10.8108108108108	0.0454508219606597	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	MUC1; MUC3A; MUC21; MUC20; MUC15; MUC16; MUCL1; MUC13;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	8	112	7.14285714285714	0.0455284403439137	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	SULT2B1; CYP2C9; VLDLR; NR0B2; NSDHL; CH25H;	GO:0008203~cholesterol metabolic process	6	73	8.21917808219178	0.0463415051729792	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
up	ADCY5; ADORA3; P2RY12; GNAI2;	GO:0001973~G protein-coupled adenosine receptor signaling pathway	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	MS4A1; ORAI1; ORAI3; ORAI2;	GO:0002115~store-operated calcium entry	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	CD48; IRF1; FCGR2B; DUSP10;	GO:0002819~regulation of adaptive immune response	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	FOLR2; SLC19A1; PDPN; SLC25A32;	GO:0015884~folic acid transport	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	BCL3; IL10; LILRB1; GHSR;	GO:0042536~negative regulation of tumor necrosis factor biosynthetic process	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	F2R; CD177; NLGN2; MYADM;	GO:0045217~cell-cell junction maintenance	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	TNF; TNFRSF1A; FADD; TRADD;	GO:0071550~death-inducing signaling complex assembly	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	ELANE; SELP; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.0468553435272238	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
up	CCL24; CREB3; PLAU; RNASE2; TYMP; L1CAM; OR1D2; CCR6; NCKAP1L; CCL23; CMTM8; CMTM2; CMTM5; CMTM7; CMTM3; CXCL16; PROK2; CCL26; CXCR3; CCR10; CCR8; CXCR5; CXCR1; CCR2; CCR5;	GO:0006935~chemotaxis	25	122	20.4918032786885	0.0470090592217892	0.898420026309076	1	1	0.999999999921875	0.999999999921875	1
down	CFAP69; OVOL1; CTSV; GJB3; AR; CCNB1; GJA1; TSPAN8; KRT9; ADCYAP1R1; HSPA2; BNC1; TYRO3; WFDC2; ODF4; SPATA19; LGR4; SOX17; BCL2L10; NPAP1; THEG;	GO:0007283~spermatogenesis	21	407	5.15970515970516	0.047707605293288	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	DLG2; PARD3; LRRC1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	3	22	13.6363636363636	0.0479910083678752	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	GLI2; BMP7; HNF1B;	GO:0048754~branching morphogenesis of an epithelial tube	3	22	13.6363636363636	0.0479910083678752	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	SRRM4; ESRP1; ESRP2; RBM20;	GO:0043484~regulation of RNA splicing	4	38	10.5263157894737	0.048972858117734	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	EPHA2; KDR; TYRO3; TMEM100;	GO:0043491~protein kinase B signaling	4	38	10.5263157894737	0.048972858117734	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	RBP1; HNF4A; ABCA12; ACOX2;	GO:0055088~lipid homeostasis	4	38	10.5263157894737	0.048972858117734	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	CACNA1G; JUP; DSP; KCNJ5;	GO:0086091~regulation of heart rate by cardiac conduction	4	38	10.5263157894737	0.048972858117734	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	CCL22; DEFB4A; CXCL14; C1QC; SLPI; CD1A; CD1E; ENDOU; DEFB1; CX3CL1; GBP6; CCL19; IL36B; IL36A; IL19; CXCL10; RAET1G; RAET1L; AZGP1; CXCL9; RAET1E; CXCL11;	GO:0006955~immune response	22	433	5.08083140877598	0.0496003518430904	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
down	OVOL1; GLI2; HNF1B; ITGA8; WNT4; TFAP2B; STRA6;	GO:0001822~kidney development	7	94	7.4468085106383	0.0498403524758123	0.234165482879345	1	1	0.999999575044437	0.999999575044437	1
